OMIDRIA

Videos From OMIDRIA

One Solution, Many Applications

Cathleen M. McCabe, MD; and Neda Shamie, MD

More Than Meets the Eye

Cathleen M. McCabe, MD; and Neda Shamie, MD

Taking the Challenge

Cathleen M. McCabe, MD; and Neda Shamie, MD

Witness Dramatic Change

William F. Wiley, MD; and Arjan Hura, MD

One Vial, Lasting Effects

William F. Wiley, MD; and Arjan Hura, MD

The Proof is in the Post-Op

William F. Wiley, MD; and Arjan Hura, MD

Resources

Blocking the Inflammatory Cascade

View Resource

Controlling Postoperative Inflammation and Associated Complications With OMIDRIA

View Resource

About OMIDRIA

Visit us online: omidriahcp.com

Contact Us

Follow OMIDRIA

INDICATIONS AND USAGE

OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

IMPORTANT SAFETY INFORMATION

OMIDRIA must be added to irrigating solution prior to intraocular use.

OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.

Systemic exposure to phenylephrine may cause elevations in blood pressure.

Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.

The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA.

You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

US-OM-2200034 10/22